Company Data
Y-mAbs Therapeutics Inc.
Ticker
YMAB
Current Price
$6.24 1.13%
Market Cap
$279.5M
Price Target
Refer to Report
Volume
903.7K
52wk Range
$5.6 - $20.9
Overview
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others.